Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catal...

por Vucic, Steve, Kiernan, Matthew C, Menon, Parvathi, Huynh, William, Rynders, Austin, Ho, Karen S, Glanzman, Robert, Hotchkin, Michael T
Publicado 2021

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension

por Vucic, Steve, Menon, Parvathi, Huynh, William, Mahoney, Colin, Ho, Karen S., Hartford, Alan, Rynders, Austin, Evan, Jacob, Evan, Jeremy, Ligozio, Shelia, Glanzman, Robert, Hotchkin, Michael T., Kiernan, Matthew C.
Publicado 2023

Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis

por Robinson, Andrew P., Zhang, Joanne Zhongyan, Titus, Haley E., Karl, Molly, Merzliakov, Mikhail, Dorfman, Adam R., Karlik, Stephen, Stewart, Michael G., Watt, Richard K., Facer, Benjin D., Facer, Jon D., Christian, Noah D., Ho, Karen S., Hotchkin, Michael T., Mortenson, Mark G., Miller, Robert H., Miller, Stephen D.
Publicado 2020